We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Esophageal Temperature Probe Visible on 3D Cardiac Mapping Systems May Reduce Physician Dependence on Fluoroscopy

By HospiMedica International staff writers
Posted on 10 Mar 2022

Esophageal temperature probes can be used to alert physicians to critical esophageal temperature changes that may occur during cardiac ablation procedures performed in the operating room (OR) or electrophysiology (EP) lab. More...

However, many physicians currently depend on fluoroscopy to place, position, and reposition their esophageal temperature probe during a procedure. The use of fluoroscopy requires physicians and lab personnel to wear protective lead aprons to shield themselves from radiation exposure. Now, the only commercially available multi-sensor esophageal temperature probe that provides high-density, edge-to-edge coverage of the esophagus and is visible on 3D cardiac mapping systems may help physicians reduce their dependence on fluoroscopy.

CIRCA Scientific, Inc.’s (Englewood, CO, USA) S-CATH M esophageal temperature probe has four electrodes that are placed down the centerline of the probe, enabling it to be placed, positioned, and visualized on 3D mapping without depending solely on fluoroscopy. In addition, S-CATH M features a proprietary micro-electrode design that limits the amount of exposed metal to only what is absolutely necessary to be detected on 3D cardiac mapping systems, minimizing the opportunity for radiofrequency (RF) interaction. Research has shown that esophageal temperature probes with fully exposed metal electrodes may be inadvertently heated when used in close proximity to the RF field. The S-CATH M esophageal temperature probe is now cleared for sale in the US.

"We designed S-CATH M to support physicians' efforts to minimize the amount of radiation their patients and staff are exposed to during their procedures without compromising on the features that set our portfolio of products apart," said Lee Geist, President, and CEO of CIRCA Scientific. "CIRCA Scientific is proud to join a growing community of medical device manufacturers meeting the demand for technology that enables reduced fluoroscopy use in the OR and EP Lab."

Related Links:
CIRCA Scientific, Inc. 


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.